167 related articles for article (PubMed ID: 18494155)
1. [The liver and methotrexate].
Laharie D; Terrebonne E; Vergniol J; Chanteloup E; Chabrun E; Couzigou P; de Lédinghen V
Gastroenterol Clin Biol; 2008 Feb; 32(2):134-42. PubMed ID: 18494155
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up.
Malatjalian DA; Ross JB; Williams CN; Colwell SJ; Eastwood BJ
Can J Gastroenterol; 1996 Oct; 10(6):369-75. PubMed ID: 9193771
[TBL] [Abstract][Full Text] [Related]
3. A pragmatic non-invasive assessment of liver fibrosis in patients with psoriasis, rheumatoid arthritis or Crohn's disease receiving methotrexate therapy.
Cervoni JP; Alby-Lepresle B; Weil D; Zhong P; Aubin F; Wendling D; Toussirot E; Vuitton L; Carbonnel F; Blondet R; Thévenot T; Calès P; Monnet E; Di Martino V
Clin Res Hepatol Gastroenterol; 2020; 44S():100003. PubMed ID: 33602481
[TBL] [Abstract][Full Text] [Related]
4. Comment on: Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
Boffa MJ; Smith A; Chalmers RJ
Rheumatology (Oxford); 2009 Nov; 48(11):1464; author reply 1465. PubMed ID: 19671697
[No Abstract] [Full Text] [Related]
5. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate.
Laharie D; Zerbib F; Adhoute X; Boué-Lahorgue X; Foucher J; Castéra L; Rullier A; Bertet J; Couzigou P; Amouretti M; de Lédinghen V
Aliment Pharmacol Ther; 2006 Jun; 23(11):1621-8. PubMed ID: 16696812
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial.
Barbero-Villares A; Mendoza Jiménez-Ridruejo J; Taxonera C; López-Sanromán A; Pajares R; Bermejo F; Pérez-Calle JL; Mendoza JL; Algaba A; Moreno-Otero R; Maté J; Gisbert JP;
Scand J Gastroenterol; 2012 May; 47(5):575-9. PubMed ID: 22229701
[TBL] [Abstract][Full Text] [Related]
8. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.
Lynch M; Higgins E; McCormick PA; Kirby B; Nolan N; Rogers S; Lally A; Vellinga A; Omar H; Collins P
JAMA Dermatol; 2014 Aug; 150(8):856-62. PubMed ID: 24964792
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive assessment of liver fibrosis in Crohn's disease patients exposed to methotrexate.
Llaó J; Masnou H; Romero C; Bargalló A; Gely C; Mañosa M; Gordillo J; Garcia-Planella E; Domènech E
Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):794-798. PubMed ID: 32804842
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of liver fibrosis by transient elastography in methotrexate treated patients.
Barbero-Villares A; Mendoza J; Trapero-Marugan M; Gonzalez-Alvaro I; Daudén E; Gisbert JP; Moreno-Otero R
Med Clin (Barc); 2011 Nov; 137(14):637-9. PubMed ID: 21719043
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis-liver-methotrexate interactions.
Arch Dermatol; 1973 Jul; 108(1):36-42. PubMed ID: 4716740
[No Abstract] [Full Text] [Related]
12. Methotrexate and histologic hepatic abnormalities: a meta-analysis.
Whiting-O'Keefe QE; Fye KH; Sack KD
Am J Med; 1991 Jun; 90(6):711-6. PubMed ID: 1828327
[TBL] [Abstract][Full Text] [Related]
13. Have methotrexate-induced liver fibrosis and cirrhosis become rare? A matter for reappraisal of routine liver biopsies.
Zachariae H
Dermatology; 2005; 211(4):307-8. PubMed ID: 16286736
[No Abstract] [Full Text] [Related]
14. Methotrexate induced liver disease in psoriasis.
Millward-Sadler GH; Ryan TJ
Br J Dermatol; 1974 Jun; 90(6):661-7. PubMed ID: 4853200
[No Abstract] [Full Text] [Related]
15. Psoriatic arthritis, methotrexate and the liver--are rheumatologists putting their patients at risk?
Lindsay K; Gough A
Rheumatology (Oxford); 2008 Jul; 47(7):939-41. PubMed ID: 18474510
[No Abstract] [Full Text] [Related]
16. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis.
Berends MA; Snoek J; de Jong EM; Van Krieken JH; de Knegt RJ; van Oijen MG; van de Kerkhof PC; Drenth JP
Liver Int; 2007 Jun; 27(5):639-45. PubMed ID: 17498249
[TBL] [Abstract][Full Text] [Related]
18. Drug reactions XV. Methotrexate, psoriasis and the liver.
Almeyda J; Barnardo D; Baker H
Br J Dermatol; 1971 Sep; 85(3):302-5. PubMed ID: 4939241
[No Abstract] [Full Text] [Related]
19. Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: a case-control study.
Laharie D; Seneschal J; Schaeverbeke T; Doutre MS; Longy-Boursier M; Pellegrin JL; Chabrun E; Villars S; Zerbib F; de Lédinghen V
J Hepatol; 2010 Dec; 53(6):1035-40. PubMed ID: 20801541
[TBL] [Abstract][Full Text] [Related]
20. Transient Elastography May Improve Detection of Liver Fibrosis in Psoriasis Patients Treated with Methotrexate.
Talme T; Nikamo P; Rosenberg P; Ståhle M
Acta Derm Venereol; 2017 Aug; 97(8):952-954. PubMed ID: 28422266
[No Abstract] [Full Text] [Related]
[Next] [New Search]
